We have previously shown that the presence of CD14+HLA-DRlo/neg monocytes, where the number of monocytes with low or no expression of HLA-DR was measured as a percentage and as cell counts, is a very good indicator of immune suppression in cancer patients[21]. The gene discussed is CD14; the disease is cancer.